Eli Lilly, J&J, Merck pharmaceuticals news

Johnson & Johnson's Janssen Research & Development LLC unit launched the Investigator Databank, which will aggregate administrative information about clinical trial sites and investigators, including good clinical practice training records, to reduce the time and administrative work involved in selecting trial investigators and sites. The databank, which will not include any patient data, is expected to be operational by year end. Janssen co-created the databank with Eli Lilly and Merck. ...